Capital International Investors’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,525,202
| Closed | -$231M | – | 453 |
|
|
2022
Q3 | $231M | Sell |
1,525,202
-163
| -0% | -$24.6K | 0.07% | 224 |
|
|
2022
Q2 | $222M | Sell |
1,525,365
-1,157,551
| -43% | -$169M | 0.06% | 237 |
|
|
2022
Q1 | $318M | Sell |
2,682,916
-2,322,910
| -46% | -$275M | 0.07% | 219 |
|
|
2021
Q4 | $690M | Sell |
5,005,826
-359,239
| -7% | -$49.5M | 0.15% | 145 |
|
|
2021
Q3 | $745M | Sell |
5,365,065
-275,997
| -5% | -$38.3M | 0.17% | 133 |
|
|
2021
Q2 | $548M | Buy |
5,641,062
+62,830
| +1% | +$6.1M | 0.13% | 162 |
|
|
2021
Q1 | $381M | Buy |
5,578,232
+247,254
| +5% | +$16.9M | 0.1% | 185 |
|
|
2020
Q4 | $457M | Sell |
5,330,978
-416,207
| -7% | -$35.7M | 0.12% | 163 |
|
|
2020
Q3 | $374M | Sell |
5,747,185
-262,830
| -4% | -$17.1M | 0.12% | 167 |
|
|
2020
Q2 | $439M | Buy |
6,010,015
+6,280
| +0.1% | +$459K | 0.14% | 137 |
|
|
2020
Q1 | $204M | Buy |
6,003,735
+3,082,031
| +105% | +$105M | 0.08% | 171 |
|
|
2019
Q4 | $159M | Buy |
2,921,704
+1,508,804
| +107% | +$82.1M | 0.05% | 207 |
|
|
2019
Q3 | $58.9M | Buy |
1,412,900
+20,000
| +1% | +$834K | 0.02% | 259 |
|
|
2019
Q2 | $61M | Buy |
+1,392,900
| New | +$61M | 0.02% | 269 |
|